Protocol Ledger

NCT07144852 · Phase III · RECRUITING

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

Interventional Phase III clinical trial protocol NCT07144852 sponsored by Sun Pharmaceutical Industries in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-11-29 Enrollment: 260 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07144852
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)260 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07144852
Protocol FieldVerified Registry Value
NCT IdentifierNCT07144852
Consolidated Lead SponsorSun Pharmaceutical Industries
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment260 participants (ESTIMATED)
Registered Start Date2025-11-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07144852
Hospital Research SiteLocationSite Profile
Center for Dermatology Clinical Research, Inc.Fremont, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI